Rocket Pharmaceuticals, Inc.
RCKT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1,191,734 | $2,517,750 | $1,333,674 | $1,380,429 |
| - Cash | $163,635 | $55,904 | $140,517 | $232,694 |
| + Debt | $25,498 | $25,042 | $22,866 | $22,601 |
| Enterprise Value | $1,053,597 | $2,486,888 | $1,216,023 | $1,170,336 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$247,485 | -$236,622 | -$213,688 | -$157,807 |
| % Margin | – | – | – | – |
| Net Income | -$258,746 | -$245,595 | -$221,863 | -$169,069 |
| % Margin | – | – | – | – |
| EPS Diluted | -2.73 | -2.92 | -3.26 | -2.68 |
| % Growth | 6.5% | 10.4% | -21.6% | – |
| Operating Cash Flow | -$209,724 | -$194,916 | -$178,142 | -$121,163 |
| Capital Expenditures | -$5,862 | -$16,472 | -$8,619 | -$7,715 |
| Free Cash Flow | -$215,586 | -$211,388 | -$186,761 | -$128,878 |